Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Sex differences in cytokine production following West Nile virus infection: Implications for symptom manifestation.

Hoffman KW, Lee JJ, Foster GA, Krysztof D, Stramer SL, Lim JK.

Pathog Dis. 2019 Mar 1;77(2). pii: ftz016. doi: 10.1093/femspd/ftz016.

PMID:
30915442
2.

Dengue Virus Immunity Increases Zika Virus-Induced Damage during Pregnancy.

Brown JA, Singh G, Acklin JA, Lee S, Duehr JE, Chokola AN, Frere JJ, Hoffman KW, Foster GA, Krysztof D, Cadagan R, Jacobs AR, Stramer SL, Krammer F, García-Sastre A, Lim JK.

Immunity. 2019 Mar 19;50(3):751-762.e5. doi: 10.1016/j.immuni.2019.01.005. Epub 2019 Feb 5.

PMID:
30737148
3.

Blood donor testing for hepatitis B virus in the United States: is there a case for continuation of hepatitis B surface antigen detection?

Dodd RY, Nguyen ML, Krysztof DE, Notari EP, Stramer SL.

Transfusion. 2018 Sep;58(9):2166-2170. doi: 10.1111/trf.14784. Epub 2018 Aug 24.

PMID:
30144082
4.

Investigational Testing for Zika Virus among U.S. Blood Donors.

Saá P, Proctor M, Foster G, Krysztof D, Winton C, Linnen JM, Gao K, Brodsky JP, Limberger RJ, Dodd RY, Stramer SL.

N Engl J Med. 2018 May 10;378(19):1778-1788. doi: 10.1056/NEJMoa1714977.

5.

Tick-Borne Encephalitis Virus Vaccine-Induced Human Antibodies Mediate Negligible Enhancement of Zika Virus Infection InVitro and in a Mouse Model.

Duehr J, Lee S, Singh G, Foster GA, Krysztof D, Stramer SL, Bermúdez González MC, Menichetti E, Geretschläger R, Gabriel C, Simon V, Lim JK, Krammer F.

mSphere. 2018 Feb 7;3(1). pii: e00011-18. doi: 10.1128/mSphereDirect.00011-18. eCollection 2018 Jan-Feb.

6.

Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity.

Bardina SV, Bunduc P, Tripathi S, Duehr J, Frere JJ, Brown JA, Nachbagauer R, Foster GA, Krysztof D, Tortorella D, Stramer SL, García-Sastre A, Krammer F, Lim JK.

Science. 2017 Apr 14;356(6334):175-180. doi: 10.1126/science.aal4365. Epub 2017 Mar 30.

7.

Prevalence, incidence, and risk factors of human immunodeficiency virus infection in blood donors in the Southeastern United States.

Crowder LA, Steele WR, Notari EP 4th, Hopkins CK, Lima JL, Foster GA, Townsend RL, Krysztof DE, Dodd RY, Stramer SL.

Transfusion. 2017 Feb;57(2):404-411. doi: 10.1111/trf.13891. Epub 2016 Nov 2.

PMID:
27807863
8.

Development of a multisystem surveillance database for transfusion-transmitted infections among blood donors in the United States.

Dodd RY, Notari EP, Nelson D, Foster GA, Krysztof DE, Kaidarova Z, Milan-Benson L, Kessler DA, Shaz BH, Vahidnia F, Custer B, Stramer SL; NHLBI Retrovirus Epidemiology Donor Study (REDS)-II.

Transfusion. 2016 Nov;56(11):2781-2789. doi: 10.1111/trf.13759. Epub 2016 Aug 25.

PMID:
27557553
9.

Recent viral infection in US blood donors and health-related quality of life (HRQOL).

Vahidnia F, Stramer SL, Kessler D, Shaz B, Leparc G, Krysztof DE, Glynn SA, Custer B.

Qual Life Res. 2017 Feb;26(2):349-357. doi: 10.1007/s11136-016-1392-5. Epub 2016 Aug 17.

PMID:
27534773
10.

Motivations for donating and attitudes toward screening policies in US blood donors with viral infection.

Vahidnia F, Stramer SL, Kessler D, Gonçalez TT, Shaz BH, Leparc G, Krysztof DE, Dodd RY, Glynn SA, Custer B; NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II).

Transfusion. 2016 Aug;56(8):2013-20. doi: 10.1111/trf.13678. Epub 2016 Jun 28.

PMID:
27351292
11.

Differences in Early Cytokine Production Are Associated With Development of a Greater Number of Symptoms Following West Nile Virus Infection.

Hoffman KW, Sachs D, Bardina SV, Michlmayr D, Rodriguez CA, Sum J, Foster GA, Krysztof D, Stramer SL, Lim JK.

J Infect Dis. 2016 Aug 15;214(4):634-43. doi: 10.1093/infdis/jiw179. Epub 2016 May 3.

12.

Distribution of Dengue Virus Types 1 and 4 in Blood Components from Infected Blood Donors from Puerto Rico.

Añez G, Heisey DA, Chancey C, Fares RC, Espina LM, Souza KP, Teixeira-Carvalho A, Krysztof DE, Foster GA, Stramer SL, Rios M.

PLoS Negl Trop Dis. 2016 Feb 12;10(2):e0004445. doi: 10.1371/journal.pntd.0004445. eCollection 2016 Feb.

13.

Genomic Assays for Identification of Chikungunya Virus in Blood Donors, Puerto Rico, 2014.

Chiu CY, Bres V, Yu G, Krysztof D, Naccache SN, Lee D, Pfeil J, Linnen JM, Stramer SL.

Emerg Infect Dis. 2015 Aug;21(8):1409-13. doi: 10.3201/eid2108.150458.

14.

Risk factors for retrovirus and hepatitis virus infections in accepted blood donors.

Custer B, Kessler D, Vahidnia F, Leparc G, Krysztof DE, Shaz B, Kamel H, Glynn S, Dodd RY, Stramer SL; NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II).

Transfusion. 2015 May;55(5):1098-107. doi: 10.1111/trf.12951. Epub 2014 Dec 4.

15.

Investigational screening for Babesia microti in a large repository of blood donor samples from nonendemic and endemic areas of the United States.

Moritz ED, Winton CS, Johnson ST, Krysztof DE, Townsend RL, Foster GA, Devine P, Molloy P, Brissette E, Berardi VP, Stramer SL.

Transfusion. 2014 Sep;54(9):2226-36. doi: 10.1111/trf.12693. Epub 2014 May 28.

PMID:
24865803
16.

Comparison of seven hepatitis B virus (HBV) nucleic acid testing assays in selected samples with discrepant HBV marker results from United States blood donors.

Enjalbert F, Krysztof DE, Candotti D, Allain JP, Stramer SL.

Transfusion. 2014 Oct;54(10):2485-95. doi: 10.1111/trf.12653. Epub 2014 Apr 17.

PMID:
24738835
17.

Donors deferred for self-reported Chagas disease history: does it reduce risk?

Steele WR, Hewitt EH, Kaldun AM, Krysztof DE, Dodd RY, Stramer SL.

Transfusion. 2014 Aug;54(8):2092-7. doi: 10.1111/trf.12590. Epub 2014 Mar 6.

PMID:
24601956
18.

Hepatitis B virus testing by minipool nucleic acid testing: does it improve blood safety?

Stramer SL, Notari EP, Krysztof DE, Dodd RY.

Transfusion. 2013 Oct;53(10 Pt 2):2449-58. doi: 10.1111/trf.12213. Epub 2013 Apr 23.

19.

Comparative analysis of triplex nucleic acid test assays in United States blood donors.

Stramer SL, Krysztof DE, Brodsky JP, Fickett TA, Reynolds B, Dodd RY, Kleinman SH.

Transfusion. 2013 Oct;53(10 Pt 2):2525-37. doi: 10.1111/trf.12178. Epub 2013 Apr 3.

20.

Dengue viremia in blood donors identified by RNA and detection of dengue transfusion transmission during the 2007 dengue outbreak in Puerto Rico.

Stramer SL, Linnen JM, Carrick JM, Foster GA, Krysztof DE, Zou S, Dodd RY, Tirado-Marrero LM, Hunsperger E, Santiago GA, Muñoz-Jordan JL, Tomashek KM.

Transfusion. 2012 Aug;52(8):1657-66. doi: 10.1111/j.1537-2995.2012.03566.x. Epub 2012 Feb 17.

PMID:
22339201
21.

Genetic diversity of recently acquired and prevalent HIV, hepatitis B virus, and hepatitis C virus infections in US blood donors.

Delwart E, Slikas E, Stramer SL, Kamel H, Kessler D, Krysztof D, Tobler LH, Carrick DM, Steele W, Todd D, Wright DJ, Kleinman SH, Busch MP; NHLBI-REDS-II Study Group.

J Infect Dis. 2012 Mar 15;205(6):875-85. doi: 10.1093/infdis/jir862. Epub 2012 Jan 31.

22.

Sensitive detection assays for influenza RNA do not reveal viremia in US blood donors.

Stramer SL, Collins C, Nugent T, Wang X, Fuschino M, Heitman JW, Law J, Krysztof DE, Kiely N, Todd D, Vermeulen NM, Harrington K, Kamel H, Kelvin DJ, Busch MP, St George K, Hewlett IK, Linnen JM, Norris PJ; NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II).

J Infect Dis. 2012 Mar 15;205(6):886-94. doi: 10.1093/infdis/jir863. Epub 2012 Jan 31.

23.

Xenotropic murine leukemia virus-related virus does not pose a risk to blood recipient safety.

Dodd RY, Hackett J Jr, Linnen JM, Dorsey K, Wu Y, Zou S, Qiu X, Swanson P, Schochetman G, Gao K, Carrick JM, Krysztof DE, Stramer SL.

Transfusion. 2012 Feb;52(2):298-306. doi: 10.1111/j.1537-2995.2011.03450.x. Epub 2011 Nov 21.

PMID:
22098340
24.

Sensitivity comparison of two Food and Drug Administration-licensed, triplex nucleic acid test automated assays for hepatitis B virus DNA detection and associated projections of United States yield.

Stramer SL, Krysztof DE, Brodsky JP, Fickett TA, Reynolds B, Phikulsod S, Oota S, Lin M, Saldanha J, Kleinman SH.

Transfusion. 2011 Sep;51(9):2012-22. doi: 10.1111/j.1537-2995.2011.03140.x. Epub 2011 Apr 19.

PMID:
21896033
25.

Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value?

Stramer SL, Zou S, Notari EP, Foster GA, Krysztof DE, Musavi F, Dodd RY.

Transfusion. 2012 Feb;52(2):440-6. doi: 10.1111/j.1537-2995.2011.03283.x. Epub 2011 Aug 2.

PMID:
21810101
26.

Human T-lymphotropic virus antibody screening of blood donors: rates of false-positive results and evaluation of a potential donor reentry algorithm.

Stramer SL, Notari EP 4th, Zou S, Krysztof DE, Brodsky JP, Tegtmeier GE, Dodd RY.

Transfusion. 2011 Apr;51(4):692-701. doi: 10.1111/j.1537-2995.2010.02903.x. Epub 2010 Oct 7.

PMID:
20946198
27.

Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing.

Zou S, Dorsey KA, Notari EP, Foster GA, Krysztof DE, Musavi F, Dodd RY, Stramer SL.

Transfusion. 2010 Jul;50(7):1495-504. doi: 10.1111/j.1537-2995.2010.02622.x. Epub 2010 Mar 12.

PMID:
20345570
28.

CCR5 deficiency is a risk factor for early clinical manifestations of West Nile virus infection but not for viral transmission.

Lim JK, McDermott DH, Lisco A, Foster GA, Krysztof D, Follmann D, Stramer SL, Murphy PM.

J Infect Dis. 2010 Jan 15;201(2):178-85. doi: 10.1086/649426.

29.

Current incidence and residual risk of hepatitis B infection among blood donors in the United States.

Zou S, Stramer SL, Notari EP, Kuhns MC, Krysztof D, Musavi F, Fang CT, Dodd RY.

Transfusion. 2009 Aug;49(8):1609-20. doi: 10.1111/j.1537-2995.2009.02195.x.

PMID:
19413732
30.

Genetic variation in OAS1 is a risk factor for initial infection with West Nile virus in man.

Lim JK, Lisco A, McDermott DH, Huynh L, Ward JM, Johnson B, Johnson H, Pape J, Foster GA, Krysztof D, Follmann D, Stramer SL, Margolis LB, Murphy PM.

PLoS Pathog. 2009 Feb;5(2):e1000321. doi: 10.1371/journal.ppat.1000321. Epub 2009 Feb 27.

Supplemental Content

Loading ...
Support Center